Skip to content

Clinical trials

Phase 2 Diabetes Mellitus trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Phase 2 Country / region: Brazil Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20071
20081
20102
20132
20171
20201
20211
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Unknown status3
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
ANS Pharma1
Eli Lilly and Company1
Hospital Alemão Oswaldo Cruz1
Novo Nordisk A/S1
Universidade do Vale do Sapucai1
University of Campinas, Brazil1
University of Nove de Julho1
University of Sao Paulo1
Wyeth is now a wholly owned subsidiary of Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus12
Diabetes Mellitus, Type 26
Proteinuria3
Diabetes Complications2
Diabetic Nephropathies2
Hyperlipidemias2
Renal Insufficiency, Chronic2
Callosities1
Foot Ulcer1
Insulin Resistance1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.